NEW YORK — Shiseido is preparing to unleash Benefiance Wrinkle Lifting Concentrate, its latest product derived through a research venture involving the cosmetics company, Harvard Medical School and Massachusetts General Hospital. To launch in November, the antiage item could generate first-year U.S. retail sales of $3.5 million. For more, see story, "Shiseido Hopes for Benefiance Boon."

To access this article, click here to subscribe or to log in.

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus